Biotechnology and nanotechnology
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (7)
All (7) ((7 results))
- 1. Biotechnology scientific activities in the federal government departments and agencies, 2008/2009 ArchivedStats in brief: 88-001-X201000211095Geography: CanadaDescription:
Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.
Release date: 2010-03-10 - 2. The Canadian Bioproducts Industry, 2003 and 2006 ArchivedArticles and reports: 21-004-X200900110875Geography: CanadaDescription:
This study is a comparative analysis based on data from the Statistics Canada Bioproducts Development Survey (2003) and the Bioproducts Development and Production Survey 2006. This study examines the current state of the domestic industry, changes occurring over the period, and implications for agriculture.
Release date: 2009-06-11 - 3. Agriculture's role in the Bioproducts Industry ArchivedArticles and reports: 21-004-X20060039265Geography: CanadaDescription:
This article provides a brief overview of the bioproducts industry in Canada and the important role agriculture plays in the growing market.
Release date: 2006-07-13 - Articles and reports: 21-601-M2006079Description:
The findings in this working paper highlight the importance of public support in addressing the capital requirements of functional food and nutraceutical firms and underscore the considerable burden in this respect borne by smaller sized firms.
Release date: 2006-06-15 - 5. Factors Affecting Biotechnology Innovation in Canada: Analysis of the 2001 Biotechnology Use and Development ArchivedArticles and reports: 21-601-M2006078Description:
This study explores factors which determine innovative activity within the Canadian biotechnology industry.
Release date: 2006-03-30 - 6. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (7)
Analysis (7) ((7 results))
- 1. Biotechnology scientific activities in the federal government departments and agencies, 2008/2009 ArchivedStats in brief: 88-001-X201000211095Geography: CanadaDescription:
Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.
Release date: 2010-03-10 - 2. The Canadian Bioproducts Industry, 2003 and 2006 ArchivedArticles and reports: 21-004-X200900110875Geography: CanadaDescription:
This study is a comparative analysis based on data from the Statistics Canada Bioproducts Development Survey (2003) and the Bioproducts Development and Production Survey 2006. This study examines the current state of the domestic industry, changes occurring over the period, and implications for agriculture.
Release date: 2009-06-11 - 3. Agriculture's role in the Bioproducts Industry ArchivedArticles and reports: 21-004-X20060039265Geography: CanadaDescription:
This article provides a brief overview of the bioproducts industry in Canada and the important role agriculture plays in the growing market.
Release date: 2006-07-13 - Articles and reports: 21-601-M2006079Description:
The findings in this working paper highlight the importance of public support in addressing the capital requirements of functional food and nutraceutical firms and underscore the considerable burden in this respect borne by smaller sized firms.
Release date: 2006-06-15 - 5. Factors Affecting Biotechnology Innovation in Canada: Analysis of the 2001 Biotechnology Use and Development ArchivedArticles and reports: 21-601-M2006078Description:
This study explores factors which determine innovative activity within the Canadian biotechnology industry.
Release date: 2006-03-30 - 6. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: